DrugPatentWatch Database Preview
Patent: 10,369,161
» See Plans and Pricing
Summary for Patent: 10,369,161
| Title: | Use of 2-methylene-19-NOR-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat primary hyperparathyroidism |
| Abstract: | Disclosed are methods of administering 2-methylene-19-nor-(20S)-1.alpha.,25-dihydroxyvitamin D.sub.3 to treat primary hyperparathyroidism and/or to treat and/or prevent the symptoms of primary hyperparathyroidism in as subject having or at risk for developing primary hyperparathyroidism, preferably without inducing hypercalcemia in the patient. |
| Inventor(s): | DeLuca; Hector F. (Deerfield, WI), Plum; Lori A. (Arena, WI), Clagett-Dame; Margaret (Deerfield, WI) |
| Assignee: | Wisconsin Alumni Research Foundation (Madison, WI) |
| Application Number: | 14/710,744 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,369,161 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,369,161
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 004 | 2015-01-23 | Start Trial | Wisconsin Alumni Research Foundation (Madison, WI) | 2034-12-30 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 003 | 2015-01-23 | Start Trial | Wisconsin Alumni Research Foundation (Madison, WI) | 2034-12-30 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 002 | 2015-01-23 | Start Trial | Wisconsin Alumni Research Foundation (Madison, WI) | 2034-12-30 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 001 | 2015-01-23 | Start Trial | Wisconsin Alumni Research Foundation (Madison, WI) | 2034-12-30 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 10,369,161
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2016109155 | Start Trial |
| United States of America | 2016184327 | Start Trial |
| Japan | 2018500373 | Start Trial |
| European Patent Office | 3240548 | Start Trial |
| Canada | 2969335 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
